(800)525-7111 Free Consultation

Belviq Cancer Lawsuit

Have you been diagnosed with cancer after taking Belviq? You may be entitled to compensation, and a Belviq cancer lawsuit attorney at Riddle & Brantley may be able to help.

Belviq (lorcaserin) is a prescription medicine manufactured by Eisai. Belviq is used for weight management in overweight and obese adults. While the FDA approved Belviq in 2012, in early 2020 the FDA ordered the withdrawal of Belviq and Belviq XR from the U.S. market due to potential cancer risk. Those affected may qualify for a Belviq cancer lawsuit or settlement and be entitled to significant financial compensation.

“Does Belviq cause cancer?”

As far back as 2010, the FDA has raised questions about Belviq and its potential connection to cancer. In early studies, there was increased incidence of mammary and brain tumors as well as adenocarcinoma (a type of cancer in glandular cells) in laboratory rates exposed to Belviq.

Despite these cancer concerns, the FDA approved Belviq as a weight management drug for the U.S. market in 2012. In 2016, Belviq XR (an extended release version) was approved, as well.

However, approval of Belviq was based in part on a requirement that long-term studies be conducted in order to evaluate the drug’s safety.

In 2018, the Belviq long-term study concluded, finding that many different types of cancers occurred more frequently in patients taking Belviq and Belviq XR.

Cancers Potentially Caused by Belviq (Lorcaserin)

The trial involved 12,000 patients studied over 5 years, and determined that Belviq may place patients at higher risk of developing certain types of cancer, including:

  • Pancreatic cancer
  • Colorectal cancer
  • Lung cancer
  • Breast cancer

Belviq Cancer Risk - Belviq Cancer Lawsuit - Riddle & BrantleyAdditional cancers may potentially be caused by lorcarserin (Belviq and Belviq XR) and research is ongoing. If you believe you may have a claim, please contact our Belviq cancer attorneys at 1-800-525-7111 or by completing the short form below.

In mid-February 2020, the FDA officially called for the withdrawal of Belviq and Belviq XR due to increased cancer risk associated with the medication.

In its announcement, the FDA stated that the “potential risk of cancer outweighs the benefits.”

“Potential risk of cancer outweighs the benefits [of Belviq].”

-FDA statement on Belviq cancer risk

If you’ve taken Belviq or Belviq XR and been diagnosed with cancer, please call 1-800-525-7111 to speak with an experienced Belviq cancer lawsuit lawyer about a potential claim for compensation.

You may be entitled to significant compensation and a Belviq cancer lawsuit attorney at Riddle & Brantley can help. We will listen to you, evaluate your claim, and advise you on your best options for pursuing compensation for cancer potentially due to lorcaserin.

Call 1-800-525-7111 today to speak with a Belviq cancer lawyer about your potential claim.

The consultation is free and you won’t pay any attorney fees unless we win your case and you receive financial compensation.

“If you’ve suffered from cancer after taking Belviq or Belviq XR, you may be entitled to compensation and now is the time to have your case investigated.”

-Gene Riddle, managing partner and attorney, Riddle & Brantley

You may qualify for a Belviq lawsuit if you meet the following criteria:

  • You were prescribed Belviq (Lorcaserin) or Belviq XR, after June 2012
  • You were diagnosed with pancreatic cancer, lung cancer, breast cancer or colorectal cancer after taking Belviq
  • Your cancer diagnosis was 6 months or more after starting Belviq
  • You are under 70 years of age

What is Belviq?

Belviq is a prescription medication for weight management among overweight and obese adults. It is commonly referred to as a diet pill. In 2012 the FDA approved Belviq to treat U.S. adults with at least one weight-related condition, including type 2 diabetes, high blood pressure (hypertension), or high cholesterol.

The active ingredient in Belviq is lorcaserin. Lorcaserin activates a receptor in the brain and scientists believe this receptor’s activation can make a person feel “full” and potentially prevent over-eating.

While Belviq was approved in 2012 by the FDA, long-term studies have revealed that Belviq may cause cancer, and the FDA requested a full withdrawal from the market in 2020.

“I take Belviq. What should I do?”

Belviq Cancer Lawsuit Lawyers - Riddle & BrantleyIf you take Belviq or Belviq XR, the FDA advises you to stop taking the medication and contact your doctor immediately. Belviq alternatives may be available to you.

The FDA is not recommending cancer screenings for patients who have taken Belviq (lorcaserin) at this time.

If you have taken Belviq or Belviq XR and have additional questions, please talk with your prescribing physician right away.

If you’ve taken Belviq or Belviq XR and been diagnosed with cancer, please call 1-800-525-7111 or complete the form below for a FREE, no-obligation consultation with a Belviq cancer lawsuit attorney.

You may qualify for a Belviq lawsuit and be entitled to significant financial compensation.

Please call 1-800-525-7111 today and let’s review your case.

Why Riddle & Brantley for your Belviq cancer lawsuit?

At Riddle & Brantley, we understand what you’re going through. We’ve been helping victims of injury due to dangerous drugs for more than 35 years.

“This settlement changed me and my family’s lives.”

Linda B., Riddle & Brantley client

Since 1985, our dangerous drug attorneys have been helping hold potentially negligent drug companies accountable. We’ve recovered millions of dollars in compensation for our deserving clients (see disclaimer below).

Our team is led by Gene Riddle, an award-winning injury attorney who has been recognized by Million Dollar Advocate Forum, Multi-Million Dollar Advocates Forum, The National Trial Lawyers Top 100, and Super Lawyers. In 2014 he was awarded the Litigator Award, and he has a prestigious AV Preeminent rating from Martindale-Hubbell (see disclaimer below).

We strive to treat all our clients like family and would love to help you and your loved ones with your Belviq cancer lawsuit if we can.

“They treated my case very professionally, with respect from beginning to end.”

Joseph W., Riddle & Brantley client

Belviq Cancer Lawsuit Law Firm - Riddle & BrantleyFor a FREE, no-obligation consultation, please call 1-800-525-7111 or complete the short form below.

The consultation is free and there are no upfront costs or attorney fees unless we win your Belviq lawsuit and you are awarded compensation for cancer potentially due to Belviq or Belviq XR.

Please call 1-800-525-7111 and let’s review your case.

You must meet the following criteria in order to qualify for a Belviq cancer lawsuit:

  • You were prescribed Belviq (Lorcaserin) or Belviq XR, after June 2012
  • You were diagnosed with pancreatic cancer, lung cancer, breast cancer or colorectal cancer after taking Belviq
  • Your cancer diagnosis was 6 months or more after starting Belviq
  • You are under 70 years of age

If Belviq caused your cancer, we believe that’s wrong and we are committed to helping you seek justice and compensation however we can.

Justice Counts for those injured due to dangerous drugs. Please call Riddle & Brantley’s Belviq cancer lawyers at 1-800-525-7111 today and let’s see how we can help.

 


*** Disclaimer: The results mentioned are intended to illustrate the type of cases handled by the firm. These results do not guarantee a similar outcome, and they should not be construed to constitute a promise or guarantee of a particular result in any particular case. Every case is different, and the outcome of any case depends upon a variety of factors unique to that case.

*** Disclaimer: An attorney must meet certain requirements to join these organizations or receive these awards. For more information on Membership Criteria for Million Dollar Advocates Forum, Multi-Million Dollar Advocates Forum, Super Lawyers, The National Trial Lawyers Top 100, AV Preeminent by Martindale-Hubbell, and the Litigator Award, please visit our Membership Criteria page. These awards and memberships should not be construed as a promise or guarantee of a similar result. Each case is different and must be evaluated separately.